|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/08 | |
| A61K 47/12 | |||
| A61K 47/18 | |||
| A61K 9/48 | |||
| A61K 31/216 | |||
| A61K 31/351 | |||
| A61K 31/65 | |||
| A61K 31/7036 |
| (11) | Number of the document | 2964193 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14714013.1 |
| Date of filing the European patent application | 2014-03-05 | |
| (97) | Date of publication of the European application | 2016-01-13 |
| (45) | Date of publication and mention of the grant of the patent | 2019-12-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/020763 |
| Date | 2014-03-05 |
| (87) | Number | WO 2014/138241 |
| Date | 2014-09-12 |
| (30) | Number | Date | Country code |
| 201361772927 P | 2013-03-05 | US | |
| 201461925443 P | 2014-01-09 | US |
| (72) |
CARL, Stephen, M., US
VRETTOS, John, Stanley, US
STERN, William, US
|
| (73) |
Enteris BioPharma, Inc.,
83 Fulton Street, Boonton, NJ 07005,
US
|
| (54) | PHARMACEUTICALS FOR ORAL DELIVERY |
| PHARMACEUTICALS FOR ORAL DELIVERY |